Tourette Syndrome News and Research

RSS
Tourette syndrome (TS) is a neurological disorder characterized by repetitive, stereotyped, involuntary movements and vocalizations called tics. The disorder is named for Dr. Georges Gilles de la Tourette, the pioneering French neurologist who in 1885 first described the condition in an 86-year-old French noblewoman.

The early symptoms of TS are almost always noticed first in childhood, with the average onset between the ages of 7 and 10 years. TS occurs in people from all ethnic groups; males are affected about three to four times more often than females. It is estimated that 200,000 Americans have the most severe form of TS, and as many as one in 100 exhibit milder and less complex symptoms such as chronic motor or vocal tics or transient tics of childhood. Although TS can be a chronic condition with symptoms lasting a lifetime, most people with the condition experience their worst symptoms in their early teens, with improvement occurring in the late teens and continuing into adulthood.
Researchers unravel genetic characteristics that increase risk of developing Tourette syndrome

Researchers unravel genetic characteristics that increase risk of developing Tourette syndrome

Researchers identify first definitive risk genes for Tourette Syndrome

Researchers identify first definitive risk genes for Tourette Syndrome

UCSF-led study finds high rate of autism symptoms in children with Tourette syndrome

UCSF-led study finds high rate of autism symptoms in children with Tourette syndrome

Study identifies structural changes in genes that increase risk of Tourette syndrome

Study identifies structural changes in genes that increase risk of Tourette syndrome

Study finds thalamic DBS to be safe, effective treatment for young adults with Tourette syndrome

Study finds thalamic DBS to be safe, effective treatment for young adults with Tourette syndrome

Research sheds new light on how humans learn to behave under uncertainty

Research sheds new light on how humans learn to behave under uncertainty

Fun with exercise may help improve physical activity among young people with autism and ADHD

Fun with exercise may help improve physical activity among young people with autism and ADHD

Researchers find differences in the brain regions of children with Tourette's syndrome

Researchers find differences in the brain regions of children with Tourette's syndrome

Salk researchers develop new computer program to measure blepharosplasm severity

Salk researchers develop new computer program to measure blepharosplasm severity

Study to examine efficacy of orally administered medication in treating stuttering

Study to examine efficacy of orally administered medication in treating stuttering

Researchers find children with Tourette syndrome faster at assembling sounds than normal kids

Researchers find children with Tourette syndrome faster at assembling sounds than normal kids

New study to examine effectiveness of orally administered drug in treating stuttering

New study to examine effectiveness of orally administered drug in treating stuttering

Maternal smoking linked to increased risk for Tourette syndrome and tic disorders

Maternal smoking linked to increased risk for Tourette syndrome and tic disorders

New CBIT therapy can help lessen frequency of tics

New CBIT therapy can help lessen frequency of tics

Deutetrabenazine may help improve chorea symptoms in patients with HD

Deutetrabenazine may help improve chorea symptoms in patients with HD

New deep brain stimulation improves symptoms in Tourette's patients

New deep brain stimulation improves symptoms in Tourette's patients

Neurocrine Biosciences reports net loss of $29.3 million for fourth quarter 2015

Neurocrine Biosciences reports net loss of $29.3 million for fourth quarter 2015

Neurocrine Biosciences announces positive data from NBI-98854 Phase III trial in tardive dyskinesia

Neurocrine Biosciences announces positive data from NBI-98854 Phase III trial in tardive dyskinesia

Neurocrine completes enrollment in Phase III clinical trial of NBI-98854 in tardive dyskinesia patients

Neurocrine completes enrollment in Phase III clinical trial of NBI-98854 in tardive dyskinesia patients

First self-assessment test developed to help clinicians diagnose autism in adults

First self-assessment test developed to help clinicians diagnose autism in adults